BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3080573)

  • 1. Effect of intravenous immune globulin on natural killer cell activity: possible association with autoimmune neutropenia and idiopathic thrombocytopenia.
    Engelhard D; Waner JL; Kapoor N; Good RA
    J Pediatr; 1986 Jan; 108(1):77-81. PubMed ID: 3080573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical uses of intravenous immune globulin: immunoglobulin replacement therapy and treatment of autoimmune cytopenias.
    Sorensen RU; Kallick MD
    J Clin Apher; 1988; 4(2-3):97-103. PubMed ID: 3397376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intravenous gamma globulin in autoimmune-mediated pediatric blood dyscrasias.
    Kurtzberg J; Friedman HS; Chaffee S; Falletta JM; Kinney TR; Kurlander R; Matthews TJ; Schwartz RS
    Am J Med; 1987 Oct; 83(4A):4-9. PubMed ID: 3118707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of intravenous gamma globulin for the treatment of autoimmune neutropenia of childhood and autoimmune hemolytic anemia.
    Hilgartner MW; Bussel J
    Am J Med; 1987 Oct; 83(4A):25-9. PubMed ID: 3118705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of intravenous gamma-globulin in idiopathic thrombocytopenic purpura.
    Bussel JB
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S147-55. PubMed ID: 2477185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of idiopathic thrombocytopenic purpura and autoimmune neutropenia.
    Wordell CJ
    Pharmacotherapy; 1987; 7(2):S41-7. PubMed ID: 3299301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable response to intravenous gamma-globulin therapy in a patient with autoimmune neutropenia, thrombocytopenia, and pemphigoid.
    Novak RM; Ou DW; Sulo RM; Chen YH
    South Med J; 1988 May; 81(5):653-5. PubMed ID: 3130663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous gammaglobulin therapy for thromboneutropenic neonates of mothers with systemic lupus erythematosus.
    Hanada T; Saito K; Nagasawa T; Kabashima T; Nakahara S; Okuyama A; Takita H
    Eur J Haematol; 1987 May; 38(5):400-4. PubMed ID: 3653361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
    Blanchette VS; Kirby MA; Turner C
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous gamma globulin treatment for chronic idiopathic thrombocytopenic purpura in children.
    Warrier I; Lusher JM
    Am J Med; 1984 Mar; 76(3A):193-8. PubMed ID: 6424451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood.
    Finberg RW; Newburger JW; Mikati MA; Heller AH; Burns JC
    J Pediatr; 1992 Mar; 120(3):376-80. PubMed ID: 1538283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura.
    Blanchette VS; Luke B; Andrew M; Sommerville-Nielsen S; Barnard D; de Veber B; Gent M
    J Pediatr; 1993 Dec; 123(6):989-95. PubMed ID: 8229536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia.
    Tremblay T; Paré I; Bazin R
    Transfusion; 2013 Feb; 53(2):261-9. PubMed ID: 22670706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic thrombocytopenia and neutropenia in childhood.
    Calderwood S; Blanchette V; Doyle J; Freedman J; Stroncek D; Zipursky A
    Am J Pediatr Hematol Oncol; 1994 May; 16(2):95-101. PubMed ID: 8166375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of intravenous immune globulin in pregnant women with common variable hypogammaglobulinemia.
    Sorensen RU; Tomford JW; Gyves MT; Judge NE; Polmar SH
    Am J Med; 1984 Mar; 76(3A):73-7. PubMed ID: 6424460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutropenia as a complication of intravenous immunoglobulin (IVIG) therapy in children with immune thrombocytopenic purpura: common and non-alarming.
    Berkovitch M; Dolinski G; Tauber T; Aladjem M; Kaplinsky C
    Int J Immunopharmacol; 1999 Jun; 21(6):411-5. PubMed ID: 10405875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody.
    Bazin R; Lemieux R; Tremblay T
    Br J Haematol; 2006 Oct; 135(1):97-100. PubMed ID: 16925577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IVIG in the treatment of children with acute and chronic idiopathic thrombocytopenic purpura and the autoimmune cytopenias.
    Nugent DJ
    Clin Rev Allergy; 1992; 10(1-2):59-71. PubMed ID: 1606524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the safety of three intravenous immunoglobulin preparations in patients with primary hypogammaglobulinaemia.
    Yap PL; McClelland DB
    J Infect; 1986 Jan; 12(1):5-10. PubMed ID: 3082994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of IgG levels on the number of natural killer cells and their Fc receptors in chronic inflammatory demyelinating polyradiculoneuropathy.
    Bohn AB; Nederby L; Harbo T; Skovbo A; Vorup-Jensen T; Krog J; Jakobsen J; Hokland ME
    Eur J Neurol; 2011 Jun; 18(6):919-24. PubMed ID: 21219545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.